Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEuropean Institute of Oncology

About this trial

Lactose intolerance (LI) is considered the clinical syndrome caused by lactose malabsorption (LM).

It is possible to identify four causes of lactase deficiency defining four different types of LM: primary (genetic), secondary (acquired), congenital (alactasia), and developmental (in premature infants, so reversible).

The aim of this protocol is to investigate through an anonymous online survey the knowledge of the Italian population on clinical, pathophysiological, diagnostic and therapeutic issues of lactose intolerance. Data collected will be divulgated through a publication for both people with IL and nutritionists, enriched with tables and flow charts, to improve the knowledge on lactose intolerance and to support people suffering from this condition. The results of this survey will guide subjects suspected of suffering from lactose intolerance towards a correct diagnosis and a better management.

Eligibility criteria

Qualifiers

Subjects must be adults (≥18 years of age)

Willingness to complete the online survey

Disqualifiers

Subjects <18 years of age

Subjects not available to answer the online survey

Trial design

Treatments tested in this trial

  • Completion of online survey

Treatment groups

385 Participants
are divided into 1 treatment group

Sponsors and collaborators